top of page

This is your Feature section paragraph. Use this space to present specific credentials, benefits or special features you offer.

IGS2021 Start Up Showcase Bridge Therapeutics, Inc

Tim Peara President of Bridge Therapeutics

Bridge Therapeutics, Inc. is a development-stage pharmaceutical company pursuing FDA approval of BT‑219 for Opioid Use Disorder (OUD), and BT-205 for the treatment of chronic pain in opioid experienced patients.

8 views0 comments

Recent Posts

See All
bottom of page